收藏切换
Research progress of the active substances and functional mechanism of traditional Chinese medicine in the treatment of inflammatory bowel disease
收藏切换
Ling XU, Ming-xin JI, Jia-rui ZHANG, Yi WANG, Lu ZHAO*
Acta Pharmaceutica Sinica | 2025, 60(10) : 2944 - 2962
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(10): 2944-2962
• Reviews •
Research progress of the active substances and functional mechanism of traditional Chinese medicine in the treatment of inflammatory bowel disease
Full
Ling XU, Ming-xin JI, Jia-rui ZHANG, Yi WANG, Lu ZHAO*
Affiliations
  • College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
Published: 2025-10-12 doi: 10.16438/j.0513-4870.2025-0362
Outline
收藏切换

Inflammatory bowel disease (IBD), which mainly includes Crohn's disease and ulcerative colitis, is a chronic intestinal inflammatory disease whose etiology is not fully understood. As its global incidence increased, the clinical management of IBD still face multiple challenges, such as side effects, drug resistance, and high healthcare costs, prompting the medical community to actively search for safer and more effective alternative/complementary treatments. In this context, traditional Chinese medicine (TCM), with its holistic view and the theory of syndrome differentiation-based treatment, demonstrates significant potential in regulating immune responses, exerting anti-inflammatory effects, and repairing the damaged intestinal barrier through its multi-component and multi-target characteristics. Here we reviewed the recent progresses in the application of TCM formulae (e.g., Wumei pills, Lizhong decoction, Sishen pills, etc.) and active monomers (e.g., magnolol, ferulic acid, chlorogenic acid, etc.) in the treatment of IBD, as well as their possible mechanisms of action, in order to provide new therapeutic strategies for the clinical management of IBD and promote the integration between TCM and modern science.

inflammatory bowel disease  /  traditional Chinese medicine  /  TCM formula  /  monomer  /  intestinal barrier
许铃, 姬茗心, 张嘉瑞, 王毅, 赵璐. 治疗炎症性肠病的中药药效物质及作用机制研究进展. 药学学报, 2025 , 60 (10) : 2944 -2962 . DOI: 10.16438/j.0513-4870.2025-0362
Ling XU, Ming-xin JI, Jia-rui ZHANG, Yi WANG, Lu ZHAO. Research progress of the active substances and functional mechanism of traditional Chinese medicine in the treatment of inflammatory bowel disease[J]. Acta Pharmaceutica Sinica, 2025 , 60 (10) : 2944 -2962 . DOI: 10.16438/j.0513-4870.2025-0362
Year 2025 volume 60 Issue 10
425
209
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0362
  • Receive Date:2025-04-01
  • Online Date:2026-09-20
  • Published:2025-10-12
Article Data
Affiliations
History
  • Received:2025-04-01
  • Revised:2025-05-25
Affiliations
    College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0362
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT